{
    "organizations": [],
    "uuid": "4715a7dd929ea98200d9a81eb2170b117ea03408",
    "author": "",
    "url": "https://www.reuters.com/article/brief-aratana-therapeutics-expands-thera/brief-aratana-therapeutics-expands-therapeutic-candidate-pipeline-idUSFWN1QJ0OX",
    "ord_in_thread": 0,
    "title": "BRIEF-Aratana Therapeutics Expands Therapeutic Candidate Pipeline",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 1, 2018 / 1:48 PM / Updated 11 minutes ago BRIEF-Aratana Therapeutics Expands Therapeutic Candidate Pipeline Reuters Staff March 1 (Reuters) - Aratana Therapeutics Inc: * ARATANA THERAPEUTICS EXPANDS THERAPEUTIC CANDIDATE PIPELINE * ARATANA THERAPEUTICS INC - ANNOUNCED AN ANIMAL HEALTH RESEARCH AND DEVELOPMENT COLLABORATION WITH ASKAT INC * ARATANA THERAPEUTICS INC - LICENSED EXCLUSIVE, WORLDWIDE RIGHTS TO DEVELOP AND COMMERCIALIZE AT-019, KNOWN AS AAT-008 BY ASKAT * ARATANA THERAPEUTICS INC - AT-019 LICENSE AGREEMENT INCLUDES AN UPFRONT PAYMENT OF $0.5 MILLION; MILESTONE PAYMENTS OF UP TO $15.5 MILLION Source text for Eikon:  ",
    "published": "2018-03-01T15:48:00.000+02:00",
    "crawled": "2018-03-01T16:01:08.012+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "expands",
        "therapeutic",
        "candidate",
        "pipeline",
        "reuters",
        "staff",
        "march",
        "reuters",
        "aratana",
        "therapeutic",
        "inc",
        "aratana",
        "therapeutic",
        "expands",
        "therapeutic",
        "candidate",
        "pipeline",
        "aratana",
        "therapeutic",
        "inc",
        "announced",
        "animal",
        "health",
        "research",
        "development",
        "collaboration",
        "askat",
        "inc",
        "aratana",
        "therapeutic",
        "inc",
        "licensed",
        "exclusive",
        "worldwide",
        "right",
        "develop",
        "commercialize",
        "known",
        "askat",
        "aratana",
        "therapeutic",
        "inc",
        "license",
        "agreement",
        "includes",
        "upfront",
        "payment",
        "million",
        "milestone",
        "payment",
        "million",
        "source",
        "text",
        "eikon"
    ]
}